Latest Gliknik Inc. Stories
- Jeffrey Herpst joins Baltimore-based Gliknik Inc. to advance mid-stage clinical drug candidates in Gliknik's innovative immunomodulator program - BALTIMORE, Feb.
BALTIMORE, Jan. 5, 2010 /PRNewswire/ -- Gliknik Inc., a biopharmaceuticals company creating new cancer and immune disorder therapies, today announced an equity financing completed at a premium price. In the past seven months the company has raised $3.5 million in equity financing.
BALTIMORE, June 8 /PRNewswire/ -- Biopharmaceuticals company Gliknik Inc. announced today that the Maryland Health Care Product Development Corporation (MHCPDC) has completed an equity investment in the company.
- In medieval musical notation, a sign or neume denoting a shake or trill.